Sorry, you need to enable JavaScript to visit this website.
Initiative to provide support in the midst of the pandemic

Bayer partners Maharashtra Government to establish 100 bed Corona Care Facility at Chittegaon, Aurangabad


Mumbai, July 7, 2020: In continuation of our COVID-19 response efforts to support communities, Bayer remains privileged to extend our assistance to the Government of Maharashtra by providing its centre at Chittegaon to set-up a 100 bed Corona Care facility to treat affected patients.

Over the last few months, Bayer has been collaborating with the Maharashtra government, local officials and other organizations in the fight against COVID-19. Maharashtra has been one of the worst affected states due to COVID-19 and presently accounts for nearly one-third of India’s total cases. In these trying times, Bayer has been providing a wide-range of support to various communities and the administration including contributions to the Chief Minister’s Relief Fund.

This 4,500 sq. ft. facility at Chittegaon will augment the administration’s infrastructure by adding 100 beds to treat COVID-19 affected patients.

Simon Wiebusch, Chief Operating Officer, Crop Science Division, Bayer, said, “At Bayer our vision is, “Health for all, hunger for none”. It sets the foundation for our future and remains the benchmark against which we measure activities across the organization. We are fortunate and humbled to be in a position to support the administration in these difficult times.”

Chandrakant Shelke, Tehsildar, Paithan, Aurangabad district, said, “In today’s times when the pandemic is affecting each one of us, it is essential that we work in unison to counter the challenges. The Maharashtra Government is grateful to Bayer for opening up its plant for setting up of this Corona Care facility. It will go a long way in supporting the local communities.”

Overcoming the challenges posed by this pandemic is critical and at Bayer we remain inspired to collaborate and support various communities.


About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros. For more information, go to


Media Contacts

Arun Gopalakrishnan
Communications Business Partner – Corporate and Head of Media Relations, South Asia
Bayer Group in India
Tel: +91-22-25311835 / +91 7738283718


Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports, which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.